IL319011A - Triazinone derivatives as nlrp3 inhibitors - Google Patents
Triazinone derivatives as nlrp3 inhibitorsInfo
- Publication number
- IL319011A IL319011A IL319011A IL31901125A IL319011A IL 319011 A IL319011 A IL 319011A IL 319011 A IL319011 A IL 319011A IL 31901125 A IL31901125 A IL 31901125A IL 319011 A IL319011 A IL 319011A
- Authority
- IL
- Israel
- Prior art keywords
- triazinone derivatives
- nlrp3 inhibitors
- nlrp3
- inhibitors
- triazinone
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pulmonology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Epidemiology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP22206271 | 2022-11-09 | ||
| PCT/EP2023/080895 WO2024099992A1 (en) | 2022-11-09 | 2023-11-07 | Triazinone derivatives as nlrp3 inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL319011A true IL319011A (en) | 2025-04-01 |
Family
ID=84330531
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL319011A IL319011A (en) | 2022-11-09 | 2023-11-07 | Triazinone derivatives as nlrp3 inhibitors |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP4615841A1 (en) |
| JP (1) | JP2025539252A (en) |
| KR (1) | KR20250103639A (en) |
| CN (1) | CN120187721A (en) |
| AR (1) | AR130984A1 (en) |
| AU (1) | AU2023376398A1 (en) |
| CA (1) | CA3268380A1 (en) |
| CL (1) | CL2025001372A1 (en) |
| CO (1) | CO2025005518A2 (en) |
| CR (1) | CR20250185A (en) |
| IL (1) | IL319011A (en) |
| MX (1) | MX2025004959A (en) |
| PE (1) | PE20251696A1 (en) |
| TW (1) | TW202434581A (en) |
| WO (1) | WO2024099992A1 (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11618751B1 (en) | 2022-03-25 | 2023-04-04 | Ventus Therapeutics U.S., Inc. | Pyrido-[3,4-d]pyridazine amine derivatives useful as NLRP3 derivatives |
| US11319319B1 (en) | 2021-04-07 | 2022-05-03 | Ventus Therapeutics U.S., Inc. | Compounds for inhibiting NLRP3 and uses thereof |
| US12331048B2 (en) | 2022-10-31 | 2025-06-17 | Ventus Therapeutics U.S., Inc. | Pyrido-[3,4-d]pyridazine amine derivatives useful as NLRP3 inhibitors |
| JP2026509587A (en) * | 2023-03-23 | 2026-03-19 | 成都▲ざ▼▲霊▼生物医▲薬▼科技有限公司 | Triazine compounds and their uses |
| TW202545527A (en) | 2024-01-16 | 2025-12-01 | 英商諾得瑟拉公司 | Nlrp3 and glp-1a combination therapies |
| WO2025261430A1 (en) * | 2024-06-21 | 2025-12-26 | 成都赜灵生物医药科技有限公司 | Benzothiophene deuterated compound and use thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR119731A1 (en) * | 2019-05-17 | 2022-01-05 | Novartis Ag | NLRP3 INFLAMASOME INHIBITORS |
| WO2021219784A1 (en) * | 2020-04-30 | 2021-11-04 | Janssen Pharmaceutica Nv | New triazinoindole compounds |
-
2023
- 2023-11-07 AU AU2023376398A patent/AU2023376398A1/en active Pending
- 2023-11-07 AR ARP230102982A patent/AR130984A1/en unknown
- 2023-11-07 CA CA3268380A patent/CA3268380A1/en active Pending
- 2023-11-07 WO PCT/EP2023/080895 patent/WO2024099992A1/en not_active Ceased
- 2023-11-07 KR KR1020257015007A patent/KR20250103639A/en active Pending
- 2023-11-07 CN CN202380077717.3A patent/CN120187721A/en active Pending
- 2023-11-07 PE PE2025000898A patent/PE20251696A1/en unknown
- 2023-11-07 CR CR20250185A patent/CR20250185A/en unknown
- 2023-11-07 JP JP2025526536A patent/JP2025539252A/en active Pending
- 2023-11-07 EP EP23801748.7A patent/EP4615841A1/en active Pending
- 2023-11-07 IL IL319011A patent/IL319011A/en unknown
- 2023-11-08 TW TW112143026A patent/TW202434581A/en unknown
-
2025
- 2025-04-29 MX MX2025004959A patent/MX2025004959A/en unknown
- 2025-04-30 CO CONC2025/0005518A patent/CO2025005518A2/en unknown
- 2025-05-08 CL CL2025001372A patent/CL2025001372A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2024099992A1 (en) | 2024-05-16 |
| MX2025004959A (en) | 2025-06-02 |
| JP2025539252A (en) | 2025-12-04 |
| PE20251696A1 (en) | 2025-07-02 |
| TW202434581A (en) | 2024-09-01 |
| CO2025005518A2 (en) | 2025-05-19 |
| AR130984A1 (en) | 2025-02-05 |
| AU2023376398A1 (en) | 2025-02-13 |
| KR20250103639A (en) | 2025-07-07 |
| CL2025001372A1 (en) | 2025-06-23 |
| CA3268380A1 (en) | 2024-05-16 |
| CR20250185A (en) | 2025-06-10 |
| CN120187721A (en) | 2025-06-20 |
| EP4615841A1 (en) | 2025-09-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL319009A (en) | Triazinone derivatives as nlrp3 inhibitors | |
| HUE071498T2 (en) | Nlrp3 inhibitors | |
| EP4077328A4 (en) | Pyridopyrimidine derivatives as kras inhibitors | |
| IL287042A (en) | Nlrp3 inflammasome inhibitors | |
| SI4363406T1 (en) | Nlrp3 inflammasome inhibitors | |
| IL318258A (en) | Novel nlrp3 inflammasome inhibitors | |
| IL310403A (en) | Substituted pyridine derivatives as sarm1 inhibitors | |
| IL309013A (en) | Substituted pyrimidinyl-pyrazoles as cdk2 inhibitors | |
| IL306065A (en) | Uracil derivatives as trpa1 inhibitors | |
| IL318533A (en) | Nlrp3 inflammasome inhibitors | |
| IL320747A (en) | Piperidine derivatives as mettl3 inhibitors | |
| IL314297A (en) | N3-substituted uracil compounds as trpa1 inhibitors | |
| IL308071A (en) | Process for the preparation of nlrp3 inhibitors | |
| IL301717B2 (en) | Tetrazole derivatives as trpa1 inhibitors | |
| EP4293018A4 (en) | Compound serving as nlrp3 inhibitor | |
| IL310777A (en) | Substituted s-alaninate derivatives | |
| IL315980A (en) | Egfr inhibitors | |
| IL299172B2 (en) | Tetrazole derivatives as trpa1 inhibitors | |
| PT4171563T (en) | Tetrazole derivatives as trpa1 inhibitors | |
| PT4337652T (en) | Nlrp3 inhibitors | |
| CA3273093A1 (en) | Triazinone derivatives as nlrp3 inhibitors | |
| CA3297023A1 (en) | Triazine derivatives as nlrp3 inhibitors | |
| AU2024307670A1 (en) | Triazine derivatives as nlrp3 inhibitors | |
| HK40122649A (en) | Nlrp3 inhibitors | |
| IL321066A (en) | Proccesses for the preparation of an nlrp3 inhibitor |